Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05135117
Other study ID # H21-0053
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 31, 2021
Est. completion date November 23, 2021

Study information

Verified date February 2023
Source University of Connecticut
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

During exercise in the heat, the thermoregulatory system impacts performance in an athletic population. Increased in core body temperature could lead to development of heat-related illnesses and impair physical performance. To facilitate heat loss and optimize performance during exercise in the heat, various cooling strategies, including cold water immersion and wearable cooling devices have been previously explored. Although whole body cooling by cold water immersion is considered to be the most effective way to reduce core body temperature, this cooling method would not be feasible for athletes during practice or competition. Therefore, previous studies strongly recommended neck cooling during exercise because of the rate of heat dissipation through the large blood vessel and accessibility compared to other body part. Furthermore, multiple studies reported that the neck cooling could improve aerobic performance (i.e. running distance and time). In addition to physiological changes, human prefer to be cool in the neck region as well as the face in hot environment. Thus, local cooling of the neck is efficient way to reduce thermal discomfort during heat exposure. The novel neck cooling collar device (NeuroRescue Inc., Lafayette, LA) used in the current study may be able to produce powerful effect of conductive cooling, which result in improving performance and also reduce thermal discomfort during exercise in the heat. While this neck cooling collar would assist athletes in improving sports safety and performance by decreasing skin temperature around the neck, the effectiveness of this neck cooling collar on core temperature was not examined at this point. Moreover, other physiological and perceptual changes are important to assess along with changes in core body temperature. Therefore, this study aims to examine how internal body temperature, heart rate, perceptual measures, and athletic performance are affected by the novel neck cooling collar during exercise in the heat.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date November 23, 2021
Est. primary completion date November 23, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 35 Years
Eligibility Inclusion Criteria: 1. Physically active (at least 30 minutes of exercise 3-5 days per week) male 2. been cleared by the medical monitor for this study 3. Have a VO2max >45ml/kg/min Exclusion Criteria: 1. Have a current musculoskeletal injury that would limit their physical activity or preclude the participant from walking, jogging, running, sprinting, or cutting. 2. Chronic health problems that affect your ability to thermoregulate (disorders affecting the liver, kidneys or the ability to sweat normally) 3. Fever or current illness at the time of testing 4. History of cardiovascular, metabolic, or respiratory disease 5. A family member died for no apparent reason, had a heart attack, died from heart problems, or sudden death before the age of 50 6. Current musculoskeletal injury that limits their physical activity 7. Currently taking a medication that is known to influence body temperature (amphetamines, antihypertensives, anticholinergics, acetaminophen, diuretics, NSAIDs, aspirin) 8. Are a female. Due to the internal body temperature gradient that accompanies the menstrual cycle, inclusion of females may not provide the most controlled internal body temperature data for this study. 9. Have a history of heat related illness 10. Throat or gastroesophageal diseases including gastroesophageal reflux disease (aka, GERD) or difficulty swallowing 11. Have any allergies or adverse reactions to the cold (e.g. Cold Urticaria, Raynauds Phenomenon/Disease, or cryoglobulinaemia) 12. Any COVID-19 related symptoms including fever, cough, shortness of breath or difficulty breathing, gastrointestinal discomfort (nausea, vomiting, and/or diarrhea), repeated shaking with chills, muscle pain (unrelated to exercise), headache, sore throat, new loss of taste or smell, congestion or runny nose. 13. Participant with clinical diagnosis of COVID-19 infection or positive result on a COVID-19 test due to concern about cardiac complications.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
NeuroRescue Cooling Collar
Between bouts of exercise subjects will be provided cooling on the neck with the NeuroRescue Collar. The custom sized cooling collar has ice water (which is kept around 2 degrees celsius) that is circulated through a neoprene sleeve that is attached to their neck for the cooling period.
Ice Towel
Between bouts of exercise subjects will be provided cooling on the neck with a towel. The towel will be kept in ice water (which is kept around 2 degrees celsius) and placed around the neck of the individual during the cooling intervention period.

Locations

Country Name City State
United States University of Connecticut Storrs Connecticut

Sponsors (2)

Lead Sponsor Collaborator
University of Connecticut NeuroRescue Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Esophageal Temperature Change Esophageal Temperature Change Up to 4 weeks
Secondary Rectal Temperature Change Rectal Temperature Change Up to 4 weeks
Secondary Heart Rate Change Heart rate as beats per minute Change Up to 4 weeks
Secondary Performance Test Change Reaction Time Test Up to 4 weeks
Secondary Performance Test Change Broad jump Up to 4 weeks
Secondary Performance Test Change Agility test Up to 4 weeks
Secondary Performance Test Change 15-min time trial Up to 4 weeks
Secondary Perceptual Scale Change Rating of Perceived Exertion (6-20, lower exertion indicated by lower number) Up to 4 weeks
Secondary Perceptual Scale Change Thermal Sensation Scale (0-8, lower number indicates cooler, higher number indicates hotter sensations) Up to 4 weeks
Secondary Perceptual Scale Change Thirst Scale (1-9, 1 indicates not thirst, 9 indicates very very thirsty) Up to 4 weeks
Secondary Perceptual Scale Change Fatigue Scale (0-10, 0 indicates no fatigue, 10 indicates extreme fatigue) Up to 4 weeks
Secondary Perceptual Scale Change Environmental Symptoms questionnaire (0-70, 0 indicates no heat stress) Up to 4 weeks
Secondary Perceptual Scale Change Profile of mood states (0-260, 0 indicates lower mood disturbance) Up to 4 weeks
Secondary Cognitive Functioning Change - Automated Neuropsychological Assessment Metrics (ANAM) Test System Go/No Go (0-infinity, lower number indicates faster and more accurate response) Up to 4 weeks
Secondary Cognitive Functioning Change- Automated Neuropsychological Assessment Metrics (ANAM) Test System Spatial Processing (0-infinity, lower number indicates faster and more accurate response) Up to 4 weeks
Secondary Cognitive Functioning Change- Automated Neuropsychological Assessment Metrics (ANAM) Test System Stroop (0-infinity, lower number indicates faster and more accurate response) Up to 4 weeks
See also
  Status Clinical Trial Phase
Completed NCT04431596 - Military Alerting System for Monitoring Body Temperature During Active Cooling N/A
Completed NCT05601713 - Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling N/A
Completed NCT00940654 - The Fever and Antipyretic in Critically Illness Evaluation Study N/A
Active, not recruiting NCT05809453 - Intranasal Cocaine and Temperature Regulation During Exercise Phase 1/Phase 2
Completed NCT04915859 - Semiconductor Heat Extraction Cooling N/A
Completed NCT04613843 - Cold Water Immersion Stirring in Hyperthermic Individuals N/A
Completed NCT03689478 - Use of Immediate Hyperthermic Intravesical Chemotherapy Following TURBT N/A
Completed NCT02271607 - The Effect and Safety of Moxibustion Therapy for Overactive Bladder Patients N/A
Terminated NCT01963117 - Effectiveness of the Combined WLI and Hyperthermia for GI Cancer Liver Metastasis N/A
Completed NCT04596618 - Impact of ICE on Exercise Performance in the Heat N/A
Withdrawn NCT05710978 - Biomarkers to Assess Acute Kidney Injury Risk During Heat Strain N/A
Completed NCT05586477 - Diphenhydramine and Sweating Phase 4
Completed NCT01576822 - Sauna Detoxification Study: Pilot Feasibility Phase 1
Recruiting NCT05366270 - Peripheral Neuroimmune Mechanisms of Hyperthermia N/A
Recruiting NCT05993910 - Prospective Hyperthermia Database in Cancer Patients (HT Register)
Terminated NCT04104334 - Impact of an Optimised Monitored Anesthesia on the Patients' Recovery After Cytoreduction Surgery Plus HIPEC N/A
Not yet recruiting NCT06389604 - Preparing for Heat Waves - Enhancing Human Thermophysiological Resilience N/A
Not yet recruiting NCT05274009 - Protective Cooling Measures to Safeguard Elderly People From Dangerous Summer Heat N/A
Terminated NCT00796900 - Dantrolene for Treatment of Hyperthermia in Subarachnoidal Hemorrhage (SAH) Phase 2/Phase 3
Active, not recruiting NCT02546596 - The Effect of Electro-Hyperthermia in Preoperative Radiotherapy for Locally Advanced Rectal Cancer N/A